CG 4305 from Cayman Chemical

A stable carbacyclic PGI2 analog of that inhibits ADP-induced platelet aggregation 25% at a concentration of 50 nM;10 mg/kg (oral) or 1 mg/kg (intraduodenal) prevents thrombotic arterial occlusion